Ashok Thakkar
Overview
Explore the profile of Ashok Thakkar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Devasia T, Kareem H, Morakhia J, Thakkar A, Sarang A
J Cardiol Cases
. 2018 Dec;
10(2):62-65.
PMID: 30546507
Patent ductus arteriosus, an essential vasculature structure during fetal life that becomes abnormal after 3 months of age, may be silent. However, the incidence of silent patent ductus arteriosus is...
2.
Polavarapu A, Polavarapu R, Prajapati J, Kamlesh Thakkar , Raheem A, Mayall T, et al.
Scientifica (Cairo)
. 2015 Nov;
2015:613089.
PMID: 26579328
Background. Long lesions being implanted with drug-eluting stents (DES) are associated with relatively high restenosis rates and higher incidences of adverse events. Objectives. We aimed to examine the safety and...
3.
Nair B, Viswanathan S, George Koshy A, Gupta P, Nair N, Thakkar A
Int J Rheumatol
. 2015 Oct;
2015:930790.
PMID: 26451146
Background. Early detection of subclinical rheumatic heart disease by use of echocardiography warrants timely implementation of secondary antibiotic prophylaxis and thereby prevents or retards its related complications. Objectives. The objective...
4.
Sarma R, Prajapati J, Raheem A, Kamlesh Thakkar , Kothari S, Thakkar A
J Clin Diagn Res
. 2015 Oct;
9(8):OC23-6.
PMID: 26435986
Background: The main culprit in first-generation drug eluting stents is 'durable' polymer, whose continuous presence may impair arterial healing and ultimately have a negative impact on late outcomes. The main...
5.
Polavarapu A, Polavarapu R, Prajapati J, Raheem A, Kamlesh Thakkar , Kothari S, et al.
Int J Vasc Med
. 2015 Oct;
2015:265670.
PMID: 26421189
Objective. The main aim is to evaluate safety, efficacy, and clinical performance of the Indolimus (Sahajanand Medical Technologies Pvt. Ltd., Surat, India) sirolimus-eluting stent in high-risk diabetic population with complex...
6.
Rajasekhar D, Vanajakshamma V, Vidyasagar A, Ranganayakulu K, Babu M, Sivasankara C, et al.
Cardiovasc Diagn Ther
. 2015 Sep;
5(4):249-53.
PMID: 26331108
Background: The main aim is to evaluate prolonged safety and efficacy of the Indolimus (Sahajanand Medical Technologies Pvt. Ltd.) sirolimus-eluting coronary stent system. Methods: It was a single center, non...
7.
Patil S, Ramalingam R, Subramanyam K, Pujar D, Manjunath C, Gajiwala N, et al.
Cardiovasc Diagn Ther
. 2015 May;
5(2):145-9.
PMID: 25984455
There is a considerable debate regarding the role of genetic and the environmental factors in the pathogenesis of coronary artery disease (CAD). Since twin pairs are exposed to similar prenatal...
8.
Prabhu M, Yalakala S, Shetty R, Thakkar A, Sitapara T
J Clin Diagn Res
. 2015 May;
9(3):OC05-8.
PMID: 25954646
Introduction: The prognosis of myocardial dysfunction in critically ill patients with sepsis and its association with mortality is controversial. We aim to determine the significance of left ventricular systolic dysfunction...
9.
Banker D, Ahuja A, Sanadhya H, Purohit C, Chandra S, Sethi R, et al.
Minerva Cardioangiol
. 2015 Apr;
64(1):9-14.
PMID: 25907696
Background: The main aim of the CORE Registry was to evaluate clinical performance of the Supralimus-Core® biodegradable polymer-coated sirolimus-eluting cobalt-chromium stent (Sahajanand Medical technologies Pvt. Ltd., Surat, India) in unselected...
10.
Chandwani P, Prajapati J, Porwal S, Khambhati B, Thakkar A
J Clin Diagn Res
. 2015 Apr;
9(2):OC05-9.
PMID: 25859478
Introduction: Coronary artery disease is the most common catastrophic disease in India. The safety and effectiveness of dual vessel sirolimus-eluting stent (SES) implantation (used as an intervention in CAD) is...